We've found
2,621
archived clinical trials in
Urology
We've found
2,621
archived clinical trials in
Urology
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Updated: 12/31/1969
Voiding Function After Mid-Urethral Slings With and Without Local Anesthetic: Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Combined Spinal Epidural Urinary Retention
Updated: 12/31/1969
Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement?
Status: Enrolling
Updated: 12/31/1969
Combined Spinal Epidural Urinary Retention
Updated: 12/31/1969
Do Women Receiving Low Dose Combined Spinal Epidural for Labor Analgesia Exhibit Less Bacteriuria Using a Urinary Retention Protocol Versus Routine Urinary Catheter Placement?
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Updated: 12/31/1969
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Physical Therapy for Women With Obstetric Trauma and Anal Incontinence
Updated: 12/31/1969
Effects of Physical Therapy on Pelvic Floor Symptoms and Quality of Life in Postpartum Women Following Severe Perineal Trauma: a Randomized Controlled Trial
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
Updated: 12/31/1969
Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
Status: Enrolling
Updated: 12/31/1969
Treatment of Symptoms After Stent Placement for Urinary Tract Obstruction
Updated: 12/31/1969
Combination Versus Monotherapy With Alpha Blocker and Anticholinergics to Relieve Urinary Stent Symptoms
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Updated: 12/31/1969
E-Moms: A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Status: Enrolling
Updated: 12/31/1969
A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Updated: 12/31/1969
E-Moms: A Personalized Telehealth Intervention for Health and Weight Loss in Postpartum Women
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Updated: 12/31/1969
Protocol for Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence An RCT: Hypnotherapy Or Pharmacotherapy
Status: Enrolling
Updated: 12/31/1969
Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy
Updated: 12/31/1969
Protocol for Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence An RCT: Hypnotherapy Or Pharmacotherapy
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Cincinnati Children's Hospital Medical Center Cincinnati Center for Clinical Research and Outpatient Clinic

Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Study of OnabotulinumtoxinA for Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Pediatric Patients
Updated: 12/31/1969
BOTOX® in the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity in Patients 5 to 17 Years of Age
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Updated: 12/31/1969
L.O.C.A.L. Study -- UroLift System TOlerability and ReCovery When Administering Local Anesthesia
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Autologous Muscle Derived Cells for Female Urinary Sphincter Repair
Updated: 12/31/1969
A Double-blind, Randomized, Controlled Trial Comparing the Safety and Efficacy of AMDC-USR With Placebo in Female Subjects With Stress Urinary Incontinence
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
